Dr Rishabh Jain Profile picture
🩺 DM Medical Oncologist, AIIMS Delhi 🌍 . Let’s keep oncology interesting !
Jan 1 β€’ 6 tweets β€’ 3 min read
Every January, oncologists promise the same thing.
β€œI’ll read trials more carefully this year.”

Then we read the abstract conclusion and move on.

Here’s the uncomfortable truth:
πŸ“£ Abstracts sell drugs.
πŸ“Š Data tells the truth.

Let me show you how to autopsy a Phase III oncology trial quickly πŸ§΅πŸ‘‡

#Oncology #MedEd #MedTwitter
@OncoAlert @myESMO @ESMO_Open @ASCOImage πŸ”ͺ Kill Shot #1 – The Control Arm Test

Before admiring the new drug, interrogate the comparator.

Ask yourself:
🧠 Would you treat your patient this way today?
🧠 Was the dose optimal or conveniently low?
🧠 Was crossover allowed or blocked?

A weak control arm can manufacture a beautiful hazard ratio.

#Oncology #MedEd #MedTwitter
@OncoAlert @myESMO @ESMO_Open @ASCOImage
Dec 29, 2025 β€’ 7 tweets β€’ 3 min read
(1/7)🧡 If cancer were a lottery, whales should lose every time.

If cancer were a biological lottery, blue whales should lose every time πŸ‹

They have 1,000Γ— more cells than humans.
More cells = more mutations = more cancer.

By probability, whales should never reach adulthood.
Yet they live 90+ years.

This is Peto’s Paradox πŸ‘‡

@OncoAlert @myesmo @esmo_open
#OncoTwitter #MedTwitter #CancerBiology #ScienceTwitter #EvolutionImage (2/7) The Paradox
Cancer starts when one cell mutates and keeps dividing.

So logic says
πŸ“ˆ more cells
πŸ“ˆ more divisions
πŸ“ˆ more cancer

By that logic, a whale should be a walking tumor.
Reality says otherwise.

@OncoAlert @asco @esmo_open
#CancerResearch #Biology #ScienceExplained #MedEd #OncologyImage
Dec 21, 2025 β€’ 5 tweets β€’ 3 min read
1/5
We know BRCA1 and BRCA2 mutations both sensitize tumors to PARP inhibitors via synthetic lethality. But clinically, not all responses are equal. 🧐

Data frequently shows that BRCA2 responses are deeper and more durable than BRCA1.
Why the difference?

It comes down to their specific jobs in the DNA repair assembly line.

A short thread πŸ§΅πŸ‘‡
#MedTwitter #Oncology #PrecisionMedicine #BRCA
@OncoAlertImage 2/5
Think of Homologous Recombination (HR) repair like a construction site repairing a broken bridge. πŸŒ‰

πŸ—οΈ BRCA1 is the Site Manager: It does crucial upstream signaling, organizing the site, and preparing the broken ends.
If the manager is sick, it’s chaotic, but workers might still patch things up inefficiently.

πŸ—οΈ BRCA2 is the Crane Operator: Its main job is to directly load the actual repair materials (RAD51 proteins) onto the break.

#MedTwitter #Oncology #PrecisionMedicine #BRCA
@OncoAlertImage
Dec 17, 2025 β€’ 5 tweets β€’ 2 min read
(1/5) HER2 testing is NOT "one size fits all." 🧬
If you apply Breast Cancer scoring rules to Gastric Cancer, you are creating a recipe for false negatives.

Biology dictates the guidelines.

Here are the 3 Critical Differences between HER2 in Breast vs. Gastric/GEJ. πŸ§΅πŸ‘‡
#Oncology #MedEd #Pathology
@OncoAlertImage (2/5)
1️⃣ The Staining Pattern: "Ring" vs. "U"

β€’ Breast: We look for the classic "Chicken Wire."
β€’ Rule: Complete, circumferential membrane staining is required for 3+.

β€’ Gastric: Incomplete staining is normal.
β€’ Rule: Look for basolateral or lateral staining (a "U" shape).

πŸ’‘ Pearl: If you wait for a complete ring in Gastric cancer to call it positive, you will miss eligible patients!

#Oncology #MedEd #Pathology
@OncoAlertImage